BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10614631)

  • 1. Time- and dose-related interactions between glucocorticoid and cyclic adenosine 3',5'-monophosphate on CCAAT/enhancer-binding protein-dependent insulin-like growth factor I expression by osteoblasts.
    McCarthy TL; Ji C; Chen Y; Kim K; Centrella M
    Endocrinology; 2000 Jan; 141(1):127-37. PubMed ID: 10614631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCAAT/enhancer-binding protein delta activates insulin-like growth factor-I gene transcription in osteoblasts. Identification of a novel cyclic AMP signaling pathway in bone.
    Umayahara Y; Ji C; Centrella M; Rotwein P; McCarthy TL
    J Biol Chem; 1997 Dec; 272(50):31793-800. PubMed ID: 9395525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17beta-estradiol potently suppresses cAMP-induced insulin-like growth factor-I gene activation in primary rat osteoblast cultures.
    McCarthy TL; Ji C; Shu H; Casinghino S; Crothers K; Rotwein P; Centrella M
    J Biol Chem; 1997 Jul; 272(29):18132-9. PubMed ID: 9218447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of insulin-like growth factor I transcription by cyclic adenosine 3',5'-monophosphate (cAMP) in fetal rat bone cells through an element within exon 1: protein kinase A-dependent control without a consensus AMP response element.
    McCarthy TL; Thomas MJ; Centrella M; Rotwein P
    Endocrinology; 1995 Sep; 136(9):3901-8. PubMed ID: 7649098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the insulin-like growth factor-binding protein-5 promoter in osteoblasts by cooperative E box, CCAAT enhancer-binding protein, and nuclear factor-1 deoxyribonucleic acid-binding sequences.
    Ji C; Chen Y; Centrella M; McCarthy TL
    Endocrinology; 1999 Oct; 140(10):4564-72. PubMed ID: 10499512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid suppression of IGF I transcription in osteoblasts.
    Delany AM; Durant D; Canalis E
    Mol Endocrinol; 2001 Oct; 15(10):1781-9. PubMed ID: 11579210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fos-related antigen 2 controls protein kinase A-induced CCAAT/enhancer-binding protein beta expression in osteoblasts.
    Chang W; Rewari A; Centrella M; McCarthy TL
    J Biol Chem; 2004 Oct; 279(41):42438-44. PubMed ID: 15299028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor activation integrates complex transcriptional effects in osteoblasts, involving the growth factors TGF-β and IGF-I, and transcription factor C/EBPδ.
    McCarthy TL; Centrella M
    Gene; 2015 Nov; 573(1):129-40. PubMed ID: 26187065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between CCAAT enhancer binding protein delta and estrogen receptor alpha control insulin-like growth factor I (igf1) and estrogen receptor-dependent gene expression in osteoblasts.
    Chang W; Parra M; Centrella M; McCarthy TL
    Gene; 2005 Jan; 345(2):225-35. PubMed ID: 15716114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stratified control of IGF-I expression by hypoxia and stress hormones in osteoblasts.
    McCarthy TL; Yun Z; Madri JA; Centrella M
    Gene; 2014 Apr; 539(1):141-51. PubMed ID: 24440782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCAAT/enhancer-binding protein delta is a critical regulator of insulin-like growth factor-I gene transcription in osteoblasts.
    Umayahara Y; Billiard J; Ji C; Centrella M; McCarthy TL; Rotwein P
    J Biol Chem; 1999 Apr; 274(15):10609-17. PubMed ID: 10187857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation domains of CCAAT enhancer binding protein delta: regions required for native activity and prostaglandin E2-dependent transactivation of insulin-like growth factor I gene expression in rat osteoblasts.
    Ji C; Chang W; Centrella M; McCarthy TL
    Mol Endocrinol; 2003 Sep; 17(9):1834-43. PubMed ID: 12791769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal control of insulin-like growth factor I gene transcription in human osteoblasts: dual actions of cAMP-dependent protein kinase on CCAAT/enhancer-binding protein delta.
    Billiard J; Grewal SS; Lukaesko L; Stork PJ; Rotwein P
    J Biol Chem; 2001 Aug; 276(33):31238-46. PubMed ID: 11390399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the cAMP response element that controls transcriptional activation of the insulin-like growth factor-I gene by prostaglandin E2 in osteoblasts.
    Thomas MJ; Umayahara Y; Shu H; Centrella M; Rotwein P; McCarthy TL
    J Biol Chem; 1996 Sep; 271(36):21835-41. PubMed ID: 8702983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone.
    McCarthy TL; Centrella M; Raisz LG; Canalis E
    Endocrinology; 1991 Jun; 128(6):2895-900. PubMed ID: 1645254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulated nuclear-cytoplasmic localization of CCAAT/enhancer-binding protein delta in osteoblasts.
    Billiard J; Umayahara Y; Wiren K; Centrella M; McCarthy TL; Rotwein P
    J Biol Chem; 2001 May; 276(18):15354-61. PubMed ID: 11278589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 increases transforming growth factor-beta type III receptor expression through CCAAT enhancer-binding protein delta in osteoblasts.
    McCarthy TL; Pham TH; Knoll BI; Centrella M
    Mol Endocrinol; 2007 Nov; 21(11):2713-24. PubMed ID: 17636036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3',5'-cyclic adenosine monophosphate response element-binding protein and CCAAT enhancer-binding protein are dispensable for insulin inhibition of phosphoenolpyruvate carboxykinase transcription and for its synergistic induction by protein kinase A and glucocorticoids.
    Yeagley D; Quinn PG
    Mol Endocrinol; 2005 Apr; 19(4):913-24. PubMed ID: 15604115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.
    Lowe WL; Fu R; Banko M
    Endocrinology; 1997 Jun; 138(6):2219-26. PubMed ID: 9165004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factor C/EBPdelta in fetal lung: developmental regulation and effects of cyclic adenosine 3',5'-monophosphate and glucocorticoids.
    Breed DR; Margraf LR; Alcorn JL; Mendelson CR
    Endocrinology; 1997 Dec; 138(12):5527-34. PubMed ID: 9389540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.